MAUDE Adverse Event Report: BIOMÉRIEUX SA CHROMID CPS ELITE 100 PL TRANS - 416172

Catalog Number	416172
Medical Device Problem Code	False Negative Result (1225)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event	Malfunction
Event or Problem Description
Product description; this medium is an isolation, enumeration, and identification medium for urine specimens.This medium enables: the microbial enumeration of the specimen by means of standardized inoculation methods.The direct identification of escherichia coli.The presumptive identification of the following bacterial species or genera: enterococcus, klebsiella, enterobacter, serratia, citrobacter (kesc), proteus, morganella, providencia (pmp).Complaint description: a customer in (b)(6) complained after having obtained uncharacteristic color colony of klebsiella pneumoniae when using chromid cps elite 20 plt trans -reference (b)(4).The customer said that they had inoculated a microoganism isolated from a patient's sample on the medium chromid cps elite 20 plt trans lot 1011518800 agar plate and that after incubation they had observed a bacterial growth with pink colonies which is not the characteristic color of klebsiella pneumoniae.The customer mentioned that they had proceeded with further testing to identify the strain.The customer said that thet had performed mass spectrometry test for the sample that confirmed the strain to be klebsiella pneumoniae.As indicated in the device ifu the chromid cps elite, results and interpretation; direct identification of e.Coli: red to burgundy colonies.Some strains that show no activity, produce a pale pink to pink color.Presumptive identification to group or genus level: it is recommended to perform a gram stain if biochemical tests are used for the genus enterococcus and the kesc group.Point 3 further guidance for identification.Staphylococcus saprophyticus: small light pink colonies.Streptococcus agalactiae: bluish-violet to violet colonies.Other species: other colors or colorless colonies.Of the microorganism isolated must be followed by appropriate additional tests.The customer observed pink colonies and proceeded with further test.At the time of the assessment, there is no indication or report from the customer that this event led to or contributed to any death, serious injury, or serious deterioration in the state of health for the concerned patient.
Additional Manufacturer Narrative
Following the incorrect result (no characteristic colony coloration) observed by the customer when testing klebsiella pneumoniae strains on chromid® cps® elite agar (cpse), reference 416172, lot 1011518800 an investigation was carried out at biomérieux manufacturing site.A review of manufacturing batch record of chromid® cps® elite agar (cpse), reference 416172, lot 1011518800 used by the customer was performed and no non-conformance or deviations were identified.The results of all in-process and quality assurance release for sales test were found to be within specification.To release the product, technical laboratory quality control (qc) tests were performed on samples that were manufactured at different manufacturing times.The samples were tested for the product's appearance, ph, microbiological state and microbiological activity.The laboratory technical qc results also complied with specifications with respect to microbiological activity for all the qc strains tested.At that time, we did not observe any performance issue (sensitivity and/or specificity) in the medium; therefore, the recovery rate for all positive controls was within qc specifications.The retained samples from the impacted lot number 101151880 were tested for six qc strains mentioned on the certificate of analysis and one additional qc strain - gur negative), incubated at 33-37°c, for 18-24 hours and the expected results were obtained.The observation of different enzymatic activities in atcc strains indicates that there is no issue with the chromogenic mixture or the product, which continues to perform as it did upon its initial release.The customer returned two patient strains, identified by vitek® ms as klebsiella pneumoniae as indicated by the customer.Customer's strains were inoculated onto chromid® cps® elite agar (cpse) reference 416172 lot 1011518800 and an alternative lot (lot 1011680220).After incubation pink or grey-pink colonies were observed instead of the expected blue green.The issue reported by the customer could be reproduced.For the pink colonies: identification: klebsiella pneumoniae spp.Pneumoniae was identified with a 99% probability by vitek® 2 system.Enzymatic activities: the strain did not express -glucosidase (glu) activity (typical enzymatic pathway for kesc group) and did not express -glucuronidase (gur) activity.However, the strain did express -galactosidase (gal) activity, meaning its enzymatic profile is not the usual one.The enzymatic profile of the clinical strain is not the usual one, showing an atypical enzymatic pathway expressing -gal activity; that enzymatic profile explains why the typical blue to green color expected for the strain is not developed.To summarize, this strain showed an atypical enzymatic pathway expressing -gal activity, confirming that the problem is not product related but seems to be related to this particular clinical strain.For colonies grey pink: identification: pseudomonas luteola was identified with an 88% probability by vitek® 2 system.Enzymatic activities: the strain did not express -glucosidase (glu) activity (a typical enzymatic pathway for kesc group) and did not express -glucuronidase (gur) activity.However, the strain did express -galactosidase ( gal) activity, meaning its enzymatic profile is not the usual one.We detected a discrepancy by comparing with our biochemical identification by vitek® 2 and your vitek® ms identification (p.Luteola against of k.Pneumoniae spp pneumoniae).However, this discordance of identification could be explained by the lack of expression of -glucosidase by the pseudomonas spp, usually expressed by this germ.The enzymatic profile of the clinical strain is not the usual one, showing an atypical enzymatic pathway expressing -gal activity; that enzymatic profile explains why the typical blue to green color expected for the strain is not developed.To conclude on the enzymatic pathway characterization, this strain showed an atypical enzymatic pathway expressing -gal activity, confirming that the problem is not product-related but seems to be related to this particular clinical strain.Complaint trend analysis the review of the worldwide complaint database was performed for reference 416172, lot 1011518800 and no other complaint were found recorded against this lot.The 08 january 2026, a review of complaints indicated that only one other complaint was registered against reference 416172 in relation with no characteristic color issue coming from the same customer.No trend detected, neither on the product reference nor on the lots related to non-characteristic color issue.Conclusion: the root cause of the uncharacteristic color observed is sample related, the strains having an atypical enzymatic pathway expressing -gal activity; this enzymatic profile explains why the typical blue to green color expected for the strain is not developed.As a product performance issue was not identified, neither corrective nor preventive actions will be implemented.In mitigation of the reported issue the device instruction for use reads: ¿certain species may produce colonies of the same characteristic color as e.Coli.¿.

• Brand Name: CHROMID CPS ELITE 100 PL TRANS - 416172
• Common Device Name: CHROMID CPS ELITE 100 PL TRANS - 416172
• Manufacturer (Section D): BIOMÉRIEUX SA; 6, c de isaac newton; tres cantos; 28760 ; SP 28760
• Manufacturer (Section G): BIOMÉRIEUX, SA; 6, c de isaac newton; tres cantos; madrid 28760 ; SP 28760
• Manufacturer Contact: stefania ciranda ; 5 rue des aqueducs; craponne 69290 ; FR 69290
• MDR Report Key: 23694542
• Report Number: 3009307598-2025-00003
• Device Sequence Number: 10288271
• Product Code: JXA
• UDI-Device Identifier: 03573026443900
• UDI-Public: 03573026443900
• Combination Product (Y/N): N
• Initial Reporter Country: FR
• PMA/510(K) Number: C1 EXEMPT
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Foreign,Health Professional,User Facility
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 01/26/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 12/29/2025
• Device Catalogue Number: 416172
• Device Lot Number: 1011518800
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/14/2025
• Supplement Date Received by Manufacturer: 01/12/2026
• Initial Report FDA Received Date: 12/02/2025
• Supplement Report FDA Received Date: 01/26/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Patient Sex: Unknown